BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Attwood SE, Wilson MS. Current hurdles in the management of eosinophilic oesophagitis: The next steps. World J Gastroenterol 2013; 19(6): 790-796 [PMID: 23429800 DOI: 10.3748/wjg.v19.i6.790]
URL: https://www.wjgnet.com/1007-9327/full/v19/i6/790.htm
Number Citing Articles
1
Mary Allyson Lowry, Michael F. Vaezi, Hernan Correa, Tina Higginbotham, James C. Slaughter, Sari Acra. Mucosal Impedance Measurements Differentiate Pediatric Patients With Active Versus Inactive Eosinophilic EsophagitisJournal of Pediatric Gastroenterology and Nutrition 2018; 67(2): 198 doi: 10.1097/MPG.0000000000001943
2
Anne Lund Krarup, Asbjørn Mohr Drewes, Per Ejstrud, Peter Thaysen Laurberg, Mogens Vyberg. Implementation of a biopsy protocol to improve detection of esophageal eosinophilia: a Danish registry-based studyEndoscopy 2021; 53(01): 15 doi: 10.1055/a-1206-0852
3
Sarmed S Sami, Hasan N Haboubi, Yeng Ang, Philip Boger, Pradeep Bhandari, John de Caestecker, Helen Griffiths, Rehan Haidry, Hans-Ulrich Laasch, Praful Patel, Stuart Paterson, Krish Ragunath, Peter Watson, Peter D Siersema, Stephen E Attwood. UK guidelines on oesophageal dilatation in clinical practiceGut 2018; 67(6): 1000 doi: 10.1136/gutjnl-2017-315414
4
Shaun V. Walsh. Non-Neoplastic Pathology of the Gastrointestinal Tract2020; : 169 doi: 10.1017/9781316823026.012
5
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract2020;  doi: 10.1017/9781316823026
6
Susan Hua, Dane Cook, Marjorie M. Walker, Nicholas J. Talley. Pharmacological treatment of eosinophilic gastrointestinal disordersExpert Review of Clinical Pharmacology 2016; 9(9): 1195 doi: 10.1080/17512433.2016.1190268